Grifols (NASDAQ:GRFS) Bolsa, Opciones inusuales

Grifols

Grifols, S.A. - American Depositary Shares

Panorámica general

Noticias

Beneficios

Opciones

Pronóstico

Dividendos

Calificaciones de analistas

Interés en corto

Comercios gubernamentales

Informe de acciones

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Comments

Grifols Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL